Pearl Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 134

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.16B

  • Investors
  • 1

Pearl Therapeutics General Information

Description

Developer of therapies for the treatment of prevalent respiratory diseases. The company offers innovative solutions and products designed to address conditions such as chronic obstructive pulmonary disease, rhinosinusitis, and asthma, enabling healthcare professionals to improve patient outcomes, improve quality of life, and advance respiratory health care.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Saginaw Drive
  • Redwood City, CA 94063
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Corporate Office
  • 200 Saginaw Drive
  • Redwood City, CA 94063
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pearl Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 27-Jun-2013 $1.16B Completed Clinical Trials - General
4. Later Stage VC (Series D) 11-Feb-2013 Completed Clinical Trials - General
3. Later Stage VC (Series C) 19-Oct-2010 Completed Startup
2. Debt - General 24-Feb-2009 $8M $41.5M Completed Startup
1. Early Stage VC (Series B) 01-Jul-2008 $33.5M $33.5M Completed Startup
To view Pearl Therapeutics’s complete valuation and funding history, request access »

Pearl Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 34,000,000 $0.001000 8% $1 $0.51 0x $0.51 18.47%
Series A 4,770,037 $0.001000 8% $1.05 $1.05 1x $1.05 1.32%
To view Pearl Therapeutics’s complete cap table history, request access »

Pearl Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapies for the treatment of prevalent respiratory diseases. The company offers innovative solutions and
Drug Discovery
Redwood City, CA
134 As of 2014

Brighton, United Kingdom
 

Broomfield, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pearl Therapeutics Competitors (44)

One of Pearl Therapeutics’s 44 competitors is Enterprise Therapeutics, a Venture Capital-Backed company based in Brighton, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Enterprise Therapeutics Venture Capital-Backed Brighton, United Kingdom
Cerecin Venture Capital-Backed Broomfield, CO
Baliopharm Venture Capital-Backed Basel, Switzerland
Verve Therapeutics Formerly VC-backed Boston, MA
Verona Pharma Corporate Backed or Acquired London, United Kingdom
You’re viewing 5 of 44 competitors. Get the full list »

Pearl Therapeutics Patents

Pearl Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021260591-A1 Methods of reducing mortality in patients suffering from copd Inactive 24-Jun-2020
EP-4091652-B1 Aerosol delivery unit Active 09-Oct-2017
ES-2970740-T3 Aerosol delivery unit Active 09-Oct-2017
JP-2022122887-A Drug delivery system and related methods Active 09-Oct-2017
EP-3694590-B1 Drug delivery systems Active 09-Oct-2017 A61M15/0025
To view Pearl Therapeutics’s complete patent history, request access »

Pearl Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pearl Therapeutics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
5AM Ventures Venture Capital Minority
Nektar Therapeutics Corporation Minority
New Leaf Venture Venture Capital Minority
Vatera Healthcare Partners Venture Capital Minority
To view Pearl Therapeutics’s complete investors history, request access »

Pearl Therapeutics FAQs

  • When was Pearl Therapeutics founded?

    Pearl Therapeutics was founded in 2006.

  • Where is Pearl Therapeutics headquartered?

    Pearl Therapeutics is headquartered in Redwood City, CA.

  • What is the size of Pearl Therapeutics?

    Pearl Therapeutics has 134 total employees.

  • What industry is Pearl Therapeutics in?

    Pearl Therapeutics’s primary industry is Drug Discovery.

  • Is Pearl Therapeutics a private or public company?

    Pearl Therapeutics is a Private company.

  • What is the current valuation of Pearl Therapeutics?

    The current valuation of Pearl Therapeutics is .

  • What is Pearl Therapeutics’s current revenue?

    The current revenue for Pearl Therapeutics is .

  • How much funding has Pearl Therapeutics raised over time?

    Pearl Therapeutics has raised $175M.

  • Who are Pearl Therapeutics’s investors?

    5AM Ventures, Nektar Therapeutics, New Leaf Venture, and Vatera Healthcare Partners have invested in Pearl Therapeutics.

  • Who are Pearl Therapeutics’s competitors?

    Enterprise Therapeutics, Cerecin, Baliopharm, Verve Therapeutics, and Verona Pharma are some of the 44 competitors of Pearl Therapeutics.

  • When was Pearl Therapeutics acquired?

    Pearl Therapeutics was acquired on 27-Jun-2013.

  • Who acquired Pearl Therapeutics?

    Pearl Therapeutics was acquired by AstraZeneca.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process